Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.05
MMSI's Cash to Debt is ranked lower than
97% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.41 vs. MMSI: 0.05 )
Ranked among companies with meaningful Cash to Debt only.
MMSI' s 10-Year Cash to Debt Range
Min: 0.02  Med: 0.13 Max: No Debt
Current: 0.05
Equity to Asset 0.60
MMSI's Equity to Asset is ranked higher than
53% of the 169 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. MMSI: 0.60 )
Ranked among companies with meaningful Equity to Asset only.
MMSI' s 10-Year Equity to Asset Range
Min: 0.44  Med: 0.73 Max: 0.84
Current: 0.6
0.44
0.84
Interest Coverage 4.55
MMSI's Interest Coverage is ranked lower than
82% of the 104 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 38.48 vs. MMSI: 4.55 )
Ranked among companies with meaningful Interest Coverage only.
MMSI' s 10-Year Interest Coverage Range
Min: 1.49  Med: 35.47 Max: 7656.67
Current: 4.55
1.49
7656.67
F-Score: 8
Z-Score: 3.48
M-Score: -2.62
WACC vs ROIC
15.13%
4.68%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 8.15
MMSI's Operating margin (%) is ranked higher than
58% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.07 vs. MMSI: 8.15 )
Ranked among companies with meaningful Operating margin (%) only.
MMSI' s 10-Year Operating margin (%) Range
Min: 3.78  Med: 8.97 Max: 19.22
Current: 8.15
3.78
19.22
Net-margin (%) 4.87
MMSI's Net-margin (%) is ranked higher than
55% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.54 vs. MMSI: 4.87 )
Ranked among companies with meaningful Net-margin (%) only.
MMSI' s 10-Year Net-margin (%) Range
Min: 0.9  Med: 5.71 Max: 12.72
Current: 4.87
0.9
12.72
ROE (%) 5.95
MMSI's ROE (%) is ranked higher than
53% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.64 vs. MMSI: 5.95 )
Ranked among companies with meaningful ROE (%) only.
MMSI' s 10-Year ROE (%) Range
Min: 2.45  Med: 9.88 Max: 22.81
Current: 5.95
2.45
22.81
ROA (%) 3.40
MMSI's ROA (%) is ranked higher than
54% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.56 vs. MMSI: 3.40 )
Ranked among companies with meaningful ROA (%) only.
MMSI' s 10-Year ROA (%) Range
Min: 1.15  Med: 5.77 Max: 18.64
Current: 3.4
1.15
18.64
ROC (Joel Greenblatt) (%) 11.92
MMSI's ROC (Joel Greenblatt) (%) is ranked higher than
51% of the 180 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.56 vs. MMSI: 11.92 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MMSI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 5.56  Med: 14.79 Max: 50.79
Current: 11.92
5.56
50.79
Revenue Growth (3Y)(%) 9.10
MMSI's Revenue Growth (3Y)(%) is ranked higher than
74% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. MMSI: 9.10 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MMSI' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0.9  Med: 10.30 Max: 18.6
Current: 9.1
0.9
18.6
EBITDA Growth (3Y)(%) 9.80
MMSI's EBITDA Growth (3Y)(%) is ranked higher than
55% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.70 vs. MMSI: 9.80 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
MMSI' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -9.2  Med: 9.80 Max: 51
Current: 9.8
-9.2
51
EPS Growth (3Y)(%) -3.00
MMSI's EPS Growth (3Y)(%) is ranked lower than
68% of the 125 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. MMSI: -3.00 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
MMSI' s 10-Year EPS Growth (3Y)(%) Range
Min: -16.5  Med: 8.80 Max: 157.1
Current: -3
-16.5
157.1
» MMSI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

MMSI Guru Trades in Q2 2014

Paul Tudor Jones 49,267 sh (+27.97%)
Chuck Royce 1,877,406 sh (+3.76%)
Jim Simons 179,944 sh (-24.06%)
» More
Q3 2014

MMSI Guru Trades in Q3 2014

Paul Tudor Jones 52,092 sh (+5.73%)
Chuck Royce 1,944,906 sh (+3.60%)
Jim Simons Sold Out
» More
Q4 2014

MMSI Guru Trades in Q4 2014

Jim Simons 77,811 sh (New)
Chuck Royce 1,760,934 sh (-9.46%)
Paul Tudor Jones 12,841 sh (-75.35%)
» More
Q1 2015

MMSI Guru Trades in Q1 2015

Joel Greenblatt 12,020 sh (New)
Jim Simons 268,525 sh (+245.10%)
Paul Tudor Jones 30,733 sh (+139.33%)
Chuck Royce 1,295,664 sh (-26.42%)
» More
» Details

Insider Trades

Latest Guru Trades with MMSI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 36.42
MMSI's P/E(ttm) is ranked lower than
64% of the 108 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.60 vs. MMSI: 36.42 )
Ranked among companies with meaningful P/E(ttm) only.
MMSI' s 10-Year P/E(ttm) Range
Min: 12.95  Med: 26.75 Max: 64.78
Current: 36.42
12.95
64.78
Forward P/E 21.32
MMSI's Forward P/E is ranked higher than
50% of the 74 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.32 vs. MMSI: 21.32 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 36.10
MMSI's PE(NRI) is ranked lower than
68% of the 110 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.50 vs. MMSI: 36.10 )
Ranked among companies with meaningful PE(NRI) only.
MMSI' s 10-Year PE(NRI) Range
Min: 13.04  Med: 26.98 Max: 66.08
Current: 36.1
13.04
66.08
P/B 2.14
MMSI's P/B is ranked higher than
63% of the 171 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.86 vs. MMSI: 2.14 )
Ranked among companies with meaningful P/B only.
MMSI' s 10-Year P/B Range
Min: 1.08  Med: 2.09 Max: 4.25
Current: 2.14
1.08
4.25
P/S 1.81
MMSI's P/S is ranked higher than
66% of the 186 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.69 vs. MMSI: 1.81 )
Ranked among companies with meaningful P/S only.
MMSI' s 10-Year P/S Range
Min: 1.03  Med: 1.72 Max: 3.22
Current: 1.81
1.03
3.22
PFCF 33.48
MMSI's PFCF is ranked lower than
57% of the 81 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.91 vs. MMSI: 33.48 )
Ranked among companies with meaningful PFCF only.
MMSI' s 10-Year PFCF Range
Min: 21.77  Med: 46.56 Max: 203.73
Current: 33.48
21.77
203.73
POCF 14.48
MMSI's POCF is ranked higher than
67% of the 111 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.68 vs. MMSI: 14.48 )
Ranked among companies with meaningful POCF only.
MMSI' s 10-Year POCF Range
Min: 9.26  Med: 14.69 Max: 37.3
Current: 14.48
9.26
37.3
EV-to-EBIT 26.56
MMSI's EV-to-EBIT is ranked lower than
62% of the 117 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.23 vs. MMSI: 26.56 )
Ranked among companies with meaningful EV-to-EBIT only.
MMSI' s 10-Year EV-to-EBIT Range
Min: 8.3  Med: 18.45 Max: 44.7
Current: 26.56
8.3
44.7
PEG 7.08
MMSI's PEG is ranked lower than
83% of the 65 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.87 vs. MMSI: 7.08 )
Ranked among companies with meaningful PEG only.
MMSI' s 10-Year PEG Range
Min: 0.45  Med: 3.37 Max: 240.57
Current: 7.08
0.45
240.57
Shiller P/E 40.97
MMSI's Shiller P/E is ranked lower than
70% of the 79 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.67 vs. MMSI: 40.97 )
Ranked among companies with meaningful Shiller P/E only.
MMSI' s 10-Year Shiller P/E Range
Min: 15.29  Med: 25.82 Max: 47.06
Current: 40.97
15.29
47.06
Current Ratio 2.62
MMSI's Current Ratio is ranked higher than
52% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.55 vs. MMSI: 2.62 )
Ranked among companies with meaningful Current Ratio only.
MMSI' s 10-Year Current Ratio Range
Min: 1.82  Med: 3.00 Max: 5.18
Current: 2.62
1.82
5.18
Quick Ratio 1.39
MMSI's Quick Ratio is ranked lower than
58% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.68 vs. MMSI: 1.39 )
Ranked among companies with meaningful Quick Ratio only.
MMSI' s 10-Year Quick Ratio Range
Min: 0.77  Med: 1.43 Max: 3.56
Current: 1.39
0.77
3.56
Days Inventory 111.24
MMSI's Days Inventory is ranked higher than
61% of the 173 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 128.70 vs. MMSI: 111.24 )
Ranked among companies with meaningful Days Inventory only.
MMSI' s 10-Year Days Inventory Range
Min: 96.49  Med: 116.89 Max: 186.62
Current: 111.24
96.49
186.62
Days Sales Outstanding 49.48
MMSI's Days Sales Outstanding is ranked higher than
73% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 62.15 vs. MMSI: 49.48 )
Ranked among companies with meaningful Days Sales Outstanding only.
MMSI' s 10-Year Days Sales Outstanding Range
Min: 41.18  Med: 49.36 Max: 65.12
Current: 49.48
41.18
65.12

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 6.23
MMSI's Price/Tangible Book is ranked lower than
66% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.27 vs. MMSI: 6.23 )
Ranked among companies with meaningful Price/Tangible Book only.
MMSI' s 10-Year Price/Tangible Book Range
Min: 1.35  Med: 2.87 Max: 7.01
Current: 6.23
1.35
7.01
Price/Projected FCF 2.93
MMSI's Price/Projected FCF is ranked lower than
74% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.76 vs. MMSI: 2.93 )
Ranked among companies with meaningful Price/Projected FCF only.
MMSI' s 10-Year Price/Projected FCF Range
Min: 1.55  Med: 2.27 Max: 19.4
Current: 2.93
1.55
19.4
Price/DCF (Earnings Based) 4.49
MMSI's Price/DCF (Earnings Based) is ranked lower than
89% of the 18 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.71 vs. MMSI: 4.49 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.04
MMSI's Price/Median PS Value is ranked higher than
62% of the 163 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.24 vs. MMSI: 1.04 )
Ranked among companies with meaningful Price/Median PS Value only.
MMSI' s 10-Year Price/Median PS Value Range
Min: 0.28  Med: 0.88 Max: 2.57
Current: 1.04
0.28
2.57
Price/Peter Lynch Fair Value 3.63
MMSI's Price/Peter Lynch Fair Value is ranked lower than
89% of the 45 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.80 vs. MMSI: 3.63 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
MMSI' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.74  Med: 2.19 Max: 13.5
Current: 3.63
0.74
13.5
Price/Graham Number 3.21
MMSI's Price/Graham Number is ranked lower than
65% of the 86 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.46 vs. MMSI: 3.21 )
Ranked among companies with meaningful Price/Graham Number only.
MMSI' s 10-Year Price/Graham Number Range
Min: 0.88  Med: 1.93 Max: 3.47
Current: 3.21
0.88
3.47
Earnings Yield (Greenblatt) (%) 3.77
MMSI's Earnings Yield (Greenblatt) (%) is ranked higher than
60% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.80 vs. MMSI: 3.77 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MMSI' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 2.2  Med: 5.40 Max: 12.1
Current: 3.77
2.2
12.1
Forward Rate of Return (Yacktman) (%) 9.55
MMSI's Forward Rate of Return (Yacktman) (%) is ranked lower than
54% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.10 vs. MMSI: 9.55 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
MMSI' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -3.4  Med: 7.25 Max: 37.2
Current: 9.55
-3.4
37.2

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:MM3.Germany,
Merit Medical Systems Inc was organized in July 1987 as a Utah corporation. The Company designs, develops, manufactures and sells medical devices used in interventional and diagnostic procedures. It provides its products to physicians and healthcare professionals to enhance patient care and enable them to perform procedures safely and effectively. Its operations are divided into the following principal markets: diagnostic and interventional cardiology, interventional radiology, interventional gastroenterology, interventional pulmonology, vascular surgery, interventional nephrology, and thoracic surgery. Its devices include Rad Board, Rad Board Xtra, Rad Trac and Rad Rest, which are used for patient positioning during radial access procedures; Safeguard Pressure Assisted Device, which assists in obtaining and maintaining hemostasis after a femoral procedure, and the Air-Band Radial Compression Device, which is indicated to assist hemostasis of the radial artery puncture site while maintaining visibility. The Company's products are also used in other clinical areas such as thoracic surgery, interventional nephrology, vascular surgery, and oncology and pain management. The Company offers safety-related products and kits. Its ShortStop and ShortStop Advantage Temporary Sharps Holders address the potential safety issues associated with accidental needle sticks. Its extensive line of color-coded Medallion Syringes and the PAL Pen and Label Medication Labeling System comply with patient safety initiatives of The Joint Commission and are designed to help minimize mix-ups in administering medication. It also offers waste management products to help avoid accidental exposure to contaminated fluids such as Occupational Safety and Health Administration compliant waste disposal basins: the BackStop, BackStop+, MiniStop, MiniStop+, and DugOut. The Company offer devices used to gain and maintain vascular access while protecting the clinician from accidental cuts and needle sticks during procedures such as the Futura Safety Scalpel and angiography needles such as the Merit Advance and the SecureLoc Safety Introducer Needle. It also offers sheath introducers such as Prelude and mini access kits such as MAK and S-MAK, designed to provide clinicians with smooth, less traumatic, and convenient access to the patient's vasculature. The Company offers the Clo-Sur PLUS P.A.D, intended for the local management of bleeding wounds and the creation of a barrier to bacterial penetration. It also offers two independent, differentiated radial compression systems, the Finale Compression Device and the RADStat Radial Artery Compression Device. Its diagnostic guide wires are used to traverse vascular anatomy and aid in placing catheters and other devices such as the pre-coated InQwire Diagnostic Guide Wires. The Merit Laureate Hydrophilic Guide Wire promotes rapid catheter exchanges and minimizes friction. It also offers the BowTie Guide Wire Insertion Device, us
» More Articles for MMSI

Headlines

Articles On GuruFocus.com
Merit Medical Systems Inc. (MMSI) CFO Kent W Stanger sells 15,870 Shares Feb 11 2011 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Dec 16 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Nov 17 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Oct 18 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Sep 16 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Aug 18 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Jul 19 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Jun 17 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares May 21 2010 
Merit Medical Systems Inc. (MMSI) COO Arlin D Nelson sells 8,335 Shares Sep 25 2009 

More From Other Websites
Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the... Jul 06 2015
Merit Medical Hits 52-Week High on Solid Q1 & Product Suite - Analyst Blog Jun 18 2015
MERIT MEDICAL SYSTEMS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 28 2015
MERIT MEDICAL SYSTEMS INC Financials May 16 2015
10-Q for Merit Medical Systems, Inc. May 14 2015
Is STERIS' (STE) Stock Worth Adding to Your Portfolio Now? - Analyst Blog May 12 2015
Research and Markets: Dialysis Catheters Market in the US 2015-2019: The Usage of Alternative... May 12 2015
MERIT MEDICAL SYSTEMS INC Files SEC form 10-Q, Quarterly Report May 11 2015
Why Merit Medical Systems (MMSI) Could Beat Earnings Estimates Again - Tale of the Tape May 07 2015
MERIT MEDICAL SYSTEMS INC Files SEC form 8-K/A, Change in Directors or Principal Officers May 04 2015
Merit Medical (MMSI) Q1 Earnings, Revenues Beat; Rise Y/Y - Analyst Blog Apr 24 2015
CONMED (CNMD) Shows Strength: Stock Gains 9.9% - Tale of the Tape Apr 24 2015
Merit Medical upgraded by Barrington Research Apr 24 2015
Merit Medical Systems Inc Earnings Call scheduled for 5:00 pm ET today Apr 23 2015
Merit Medical posts 1Q profit Apr 23 2015
Merit Medical posts 1Q profit Apr 23 2015
MERIT MEDICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Apr 23 2015
Merit Medical Reports Sales Up 9% for the Quarter Ended March 31, 2015 Apr 23 2015
Merit Medical Reports Sales Up 9% for the Quarter Ended March 31, 2015 Apr 23 2015
CONMED (CNMD) Q1 Earnings, Revenues Beat; Down Y/Y - Analyst Blog Apr 23 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK